Labs / Assays & in vitro testing

DIVERCHIM
Roissy-en-France, France · diverchim.com
GMP
DIVERCHIM is a small molecule drug substance CDMO focused on developing and manufacturing high added-value active ingredients, including APIs, radiopharmaceutical precursors, GMP excipients, and linkers. It serves projects from preclinical stage to commercial supply for drug candidates, orphan drugs, rare diseases, and niche specialty chemicals near Paris, France.
They take quote requests by email.
What they offer
Small molecule API development and manufacturing
Develops and manufactures small molecule APIs, including starting materials and advanced intermediates, from preclinical stage to commercial supply.
Radiopharmaceutical precursor development and manufacturing
Develops and manufactures radiopharmaceutical precursors for nuclear medicine applications.
GMP excipients and linker supply
Produces GMP excipients and linkers for development and manufacturing programs.
Lyophilization of radiopharmaceutical precursors
Provides lyophilization services for radiopharmaceutical precursors.
Solid aliquoting of radiopharmaceutical precursors
Provides manual and automatic solid aliquoting of radiopharmaceutical precursors.
Liquid aliquoting
Provides liquid aliquoting in 2R to 50R vials.
Reference standards
Supplies reference standards as an additional service.
Standalone analytics
Provides standalone analytical services.
Quality Assurance & Regulatory support
Supports projects with quality assurance and regulatory activities under an ICHQ7-based quality system.
Project management
Manages route scouting, development, validation, stability studies, and production through dedicated project management.
GMP peptide synthesis
Performs GMP peptide synthesis using solid phase synthesis expertise and glass dedicated reactors.
Internal vectorized radiochemistry
Develops and manufactures GMP precursors and excipients using internal vectorized radiochemistry capabilities.
What they work on
- Modalities
- Small molecule, Peptide, Oligonucleotide, mRNA
- Assays and studies
- standalone analytics, reference standards, stability studies
- Instruments and platforms
- Auto-sampler filling, glass dedicated reactors, solid phase synthesis equipment, liquid aliquoting equipment
- Scale and capacity
- 3000 m² facility, g-scale GMP to dozens of kilo, 2 qualified equipment for GMP peptide synthesis, 2 equipment for liquid aliquoting (2R–50R vials)
- Therapeutic areas
- orphan drugs, rare diseases, nuclear medicine
- Type
- CRDMO
- Sites
- Paris, France
- Quality
- ICHQ7 based quality system · GMP certification of the site since 2015 (site) · EcoVadis certification
- Serves
- international hubs
- Founded
- 2015
Similar labs. Porton, VxP Biologics, Alcami, ARSI Canada Inc
Found in a contract services directory. Listing built from diverchim.com. Work here? Claim this listing.